Birdwatch Note
2022-11-17 19:21:25 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Commonly cited factors for high drug prices are: No single-payer negotiation, Lack of government regulation, Drug patents and exclusivity, Lack of comparative research across drugs. https://www.goodrx.com/healthcare-access/drug-cost-and-savings/why-are-prescription-drugs-more-expensive-in-the-us-than-in-other-countries Class action suits have been used to address manufacturer collusion to keep prices high. https://nastlaw.com/generic-drug-price-fixing-lawsuit/
Written by 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1593301248500936705
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1593323440156692480
- noteId - 1593323440156692480
- participantId - 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC
- noteAuthorParticipantId -
- createdAtMillis - 1668712885310
- tweetId - 1593301248500936705
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Commonly cited factors for high drug prices are: No single-payer negotiation, Lack of government regulation, Drug patents and exclusivity, Lack of comparative research across drugs. https://www.goodrx.com/healthcare-access/drug-cost-and-savings/why-are-prescription-drugs-more-expensive-in-the-us-than-in-other-countries Class action suits have been used to address manufacturer collusion to keep prices high. https://nastlaw.com/generic-drug-price-fixing-lawsuit/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-11-17 19:21:25 UTC (1668712885310) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC |
Note Ratings
| rated at | rated by | |
| 2022-11-17 14:04:02 -0600 | 042FCE77231C226BFD755EE2EA3278DE974666A1CD703B9318CA8D3D39365198 | Rating Details |
| 2022-11-17 14:11:41 -0600 | 082D7880988D60E41363C038B7319A83F8F316B2655E08364AE3752EA34C9EC7 | Rating Details |
| 2022-11-17 13:34:42 -0600 | 0B683F53A71314B5B037053E967D8B7476EE62CEC7C245474E462A3294BE2995 | Rating Details |
| 2022-11-18 00:15:49 -0600 | 1B14FA5B298EF5B5A2B0391BCB153D78440794A8F468C59F64BF34CA878B8C8D | Rating Details |
| 2022-11-17 15:54:21 -0600 | 1D0EE1E7326E3B7E3AE963906347A471CFE4291DA1E3F0D5FB1D98496E0A89C3 | Rating Details |
| 2022-11-17 13:54:17 -0600 | 22BEE143014A162C3B497D83C5CDE1D14E2DE8187ECE3D646E8CBF25316FF773 | Rating Details |
| 2022-11-17 19:19:54 -0600 | 2D4C83A96BA3B1DE6B629ABC08A9535751418C9761E70F4356D07687F99ABC1A | Rating Details |
| 2022-11-17 13:47:13 -0600 | 3922021E2B4C1A4B610B8FAFE0447925B4441B7A397CBAE1E446B9DE65C2A8E3 | Rating Details |
| 2022-11-17 14:35:02 -0600 | 3E6159020CC0DF5D00799DA1B18015AFBDA02FD51E440BBA230058FCD4E5ABF3 | Rating Details |
| 2022-11-17 15:14:59 -0600 | 401E20090C8F45C29392131A9F9F7F5B8E99F5E338FC76A5AC1CA2D5C90BB894 | Rating Details |
| 2022-11-17 16:17:14 -0600 | 51FB6A5D1C3DBBB80BC5A136DC1DDD92845BFBFDAA4A57983E737B947FDBB328 | Rating Details |
| 2022-11-17 13:46:52 -0600 | 5421E1484D864540C79500F4BEE07A4F3C2E26B6F153134E25D6764D5EB04CAA | Rating Details |
| 2022-11-17 13:44:23 -0600 | 5FB9B68061EDA5E93528C6A547111421B76EBB9BCE4A9F6DF39B3E468E23455C | Rating Details |
| 2022-11-17 17:01:27 -0600 | 6B5FA9F4D0BCD660DD519C21C4F646EAA6A47D2DD10B2D5314921536B8EEDDB5 | Rating Details |
| 2022-11-17 13:32:13 -0600 | 6FA5A00B2A374FF12165320F71D91F16109415E25C1B4B43902A6DC8324EF7FB | Rating Details |
| 2022-11-17 16:29:45 -0600 | 748335235B1E165D9996FB372BECA95F9D025C9C30D35A98BC455A7F9EB9C5A0 | Rating Details |
| 2022-11-17 16:20:18 -0600 | 7640BF10DEC76014715D6ADAC18E627AF02F2F4727C33862A234189728245F6C | Rating Details |
| 2022-11-17 15:28:14 -0600 | 776626EC87CACF36E33EB476A4C36DD3F1B976CF0A79AC960A7886EB223A1B3A | Rating Details |
| 2022-11-17 13:33:45 -0600 | 7BD0400C81C023A216961124BAA56A5AD5E66E315C72382F8D9B9F5908924672 | Rating Details |
| 2022-11-17 16:59:05 -0600 | 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 | Rating Details |
| 2022-11-17 14:18:47 -0600 | 805341F2454AAE7F01B4D57DC54C7C39FA36B5E1EF7FA7ED70F33F84C6C471C2 | Rating Details |
| 2022-11-17 16:06:14 -0600 | 8A4CB69F34DC3F861D6B39BFAC20736F3138EB6B55E9F6D188F9AC79288A7B8B | Rating Details |
| 2022-11-17 18:48:04 -0600 | 8FEF6EDC07A68A42569ADBF11023540DFB152A861886BC9F0AABFE09660032ED | Rating Details |
| 2022-11-17 16:09:53 -0600 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
| 2022-11-17 14:12:17 -0600 | 9D63BA103D90D8A76C6AE87E7D28DC98DD609186A0BDB59AB7FE8975ADA24401 | Rating Details |
| 2022-11-17 13:49:40 -0600 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
| 2022-11-17 16:01:22 -0600 | A8472D408C814F87AD6348A00F847BF70C2E2FB339C739B9F4D7F1F2C5941368 | Rating Details |
| 2022-11-17 15:24:18 -0600 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
| 2022-11-17 14:09:26 -0600 | ADD6D84E1F57E6163E655F2B417E4696E606ADB54DD1EDE679CED0D4F3222ABD | Rating Details |
| 2022-11-17 20:09:17 -0600 | B03D353415EE7524C0FC5E4A99FF05B4218D9AD46AC1C3CFB8123240D70C9D55 | Rating Details |
| 2022-11-17 16:10:10 -0600 | B633C548578A36FAE1AA30EB97C1655FAD1AF3A3AF2605E7352EAA5E51AB61CD | Rating Details |
| 2022-11-17 13:35:57 -0600 | B81E5BB254A609770A08D4E04F69B8CB7C54F95A427285D9EE541F8FF802D29D | Rating Details |
| 2022-11-17 16:00:19 -0600 | BA026FB7ECFA54928A42E5CA6CB8F7D7990C8080E39B181BB1069C50A50A5E03 | Rating Details |
| 2022-11-17 21:10:31 -0600 | C02ECC52E5D398AC7BD1550D6E659F4A42684AC860345B288926E487B3373AA9 | Rating Details |
| 2022-11-17 18:19:53 -0600 | CBADEC0EA85679C53CAE788671B048760653B4D60E4945082109124C6C7056F3 | Rating Details |
| 2022-11-17 14:33:20 -0600 | D1A4BA179F884EF4A94651A83807B6C2F9DE401B8B8A42F898C00F16CF50FE0E | Rating Details |
| 2022-11-17 18:31:23 -0600 | DB51004CCDA5C85C3A943D174E3B608FFD53BFECCE18EDB6FA52E0041AB09192 | Rating Details |
| 2022-11-17 22:17:35 -0600 | DC708135FE690FF25DA4019B2270046FC7217CE413921F65C47A7313528C5D73 | Rating Details |
| 2022-11-17 14:10:00 -0600 | DF8460C8FB4E1949BFCA94224BD2987227798B9BBC743E737B732C0B69985CEF | Rating Details |
| 2022-11-17 19:56:15 -0600 | E5D14674B7036F7E01BFA2406B306BDE15EEEE13A62C210836B2E02A67805870 | Rating Details |
| 2022-11-17 22:59:32 -0600 | E91E7510DF65DF36C923368403BD32781E3143AFB29F606CDA831ABC96F5D437 | Rating Details |
| 2022-11-17 13:33:24 -0600 | EA99F72E25770BBE901CD45E15DF15B9FE04CD21D35F2409E64B701AB9949F00 | Rating Details |
| 2022-11-17 13:34:42 -0600 | Rating Details | |
| 2022-11-17 20:09:17 -0600 | Rating Details | |
| 2022-11-17 19:19:54 -0600 | Rating Details | |
| 2022-11-17 14:12:17 -0600 | Rating Details | |
| 2022-11-17 13:35:57 -0600 | Rating Details | |
| 2022-11-17 16:00:19 -0600 | Rating Details | |
| 2022-11-17 13:44:23 -0600 | Rating Details | |
| 2022-11-17 17:01:27 -0600 | Rating Details | |
| 2022-11-17 18:31:23 -0600 | Rating Details | |
| 2022-11-17 15:28:14 -0600 | Rating Details | |
| 2022-11-17 16:09:53 -0600 | Rating Details | |
| 2022-11-17 21:10:31 -0600 | Rating Details | |
| 2022-11-17 13:32:13 -0600 | Rating Details | |
| 2022-11-17 15:24:18 -0600 | Rating Details | |
| 2022-11-17 22:59:32 -0600 | Rating Details | |
| 2022-11-17 18:48:04 -0600 | Rating Details | |
| 2022-11-17 14:09:26 -0600 | Rating Details | |
| 2022-11-17 13:54:17 -0600 | Rating Details | |
| 2022-11-17 14:35:02 -0600 | Rating Details | |
| 2022-11-17 16:29:45 -0600 | Rating Details | |
| 2022-11-17 13:33:24 -0600 | Rating Details | |
| 2022-11-17 18:19:53 -0600 | Rating Details | |
| 2022-11-17 22:17:35 -0600 | Rating Details | |
| 2022-11-17 16:10:10 -0600 | Rating Details | |
| 2022-11-17 16:17:14 -0600 | Rating Details | |
| 2022-11-17 16:59:05 -0600 | Rating Details | |
| 2022-11-17 13:47:13 -0600 | Rating Details | |
| 2022-11-17 13:49:40 -0600 | Rating Details | |
| 2022-11-17 14:11:41 -0600 | Rating Details | |
| 2022-11-17 13:33:45 -0600 | Rating Details | |
| 2022-11-17 16:20:18 -0600 | Rating Details | |
| 2022-11-17 15:14:59 -0600 | Rating Details | |
| 2022-11-17 14:33:20 -0600 | Rating Details | |
| 2022-11-18 00:15:49 -0600 | Rating Details | |
| 2022-11-17 14:04:02 -0600 | Rating Details | |
| 2022-11-17 19:56:15 -0600 | Rating Details | |
| 2022-11-17 13:46:52 -0600 | Rating Details | |
| 2022-11-17 16:06:14 -0600 | Rating Details | |
| 2022-11-17 15:54:21 -0600 | Rating Details | |
| 2022-11-17 14:10:00 -0600 | Rating Details | |
| 2022-11-17 14:18:47 -0600 | Rating Details | |
| 2022-11-17 16:01:22 -0600 | Rating Details |